WA
GMAB icon

Wealth Alliance’s Genmab GMAB Stock Holding History

Wealth Alliance’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Sell
13,615
-489
-3% -$14.7K 0.04% 375
2025
Q4 		$434K Sell
14,104
-49
-0.3% -$1.53K 0.04% 337
2025
Q3 		$434K Sell
14,153
-302
-2% -$7.36K 0.04% 336
2025
Q2 		$299K Buy
14,455
+327
+2% +$6.71K 0.03% 407
2025
Q1 		$277K Buy
+14,128
New +$296K 0.03% 412
2024
Q4 		– Sell
-10,043
Closed -$245K – 514
2024
Q3 		$245K Buy
+10,043
New +$268K 0.03% 453
2024
Q1 		– Sell
-8,403
Closed -$268K – 525
2023
Q4 		$268K Sell
8,403
-2,298
-21% -$72.2K 0.04% 415
2023
Q3 		$377K Buy
10,701
+134
+1% +$5.11K 0.06% 290
2023
Q2 		$402K Buy
10,567
+299
+3% +$11.9K 0.06% 295
2023
Q1 		$388K Buy
10,268
+119
+1% +$4.57K 0.06% 289
2022
Q4 		$430K Sell
10,149
-1,759
-15% -$72.5K 0.08% 260
2022
Q3 		$383K Buy
11,908
+4,172
+54% +$146K 0.08% 266
2022
Q2 		$251K Sell
7,736
-1,636
-17% -$53K 0.05% 370
2022
Q1 		$339K Buy
9,372
+552
+6% +$18.9K 0.07% 300
2021
Q4 		$349K Sell
8,820
-1,150
-12% -$48K 0.07% 298
2021
Q3 		$436K Buy
9,970
+2,074
+26% +$93.1K 0.1% 240
2021
Q2 		$322K Sell
7,896
-1,803
-19% -$69.6K 0.08% 302
2021
Q1 		$318K Sell
9,699
-408
-4% -$15.3K 0.09% 272
2020
Q4 		$411K Buy
10,107
+416
+4% +$15.6K 0.12% 204
2020
Q3 		$355K Sell
9,691
-558
-5% -$20.2K 0.13% 194
2020
Q2 		$347K Buy
+10,249
New +$279K 0.14% 192

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Wealth Alliance's GMAB Position: Q1 2026 in Review

Wealth Alliance reduced its Genmab (GMAB) stake by 3.5% in Q1 2026, selling an estimated $14.7K and leaving 13,615 shares worth $365K. The position accounts for 0.04% of the portfolio, ranked #375.

Wealth Alliance first reported a position in GMAB in Q2 2020 and has held it in 21 quarters since. The position peaked at $436K in Q3 2021. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Wealth Alliance held 13,615 shares of Genmab worth $365K as of Q1 2026.
  • Wealth Alliance sold 489 Genmab shares in Q1 2026, an estimated $14.7K.
  • Genmab made up 0.04% of Wealth Alliance's portfolio in Q1 2026, its #375 holding.
  • Wealth Alliance first reported a position in Genmab in Q2 2020 and has held it in 21 quarters since.
  • Wealth Alliance's Genmab position peaked at $436K in Q3 2021.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.